Approval of newest Alzheimer's drug will accelerate new era of treatment

With the arrival of Lilly's Kisunla, Alzheimer's care could become more like treatment of cancer and rheumatoid arthritis and their regular infusions.

Full story

#1

Physicians are in short supply. They are costly. Is the APP the answer to the CMO's workforce and budget challenges? ...

Amid the hype and promise, a growing tension is becoming clear: the reality of what AI can deliver versus what it can't. ...